Verteporfin therapy for myopic choroidal neovascularisation in Indian eyes (one year results)

Indian Journal of Ophthalmology

Volumn 52, Issue 3, 2004, Pages 227-231

  Hussain, Nazimul ^a   Das, Taraprasad ^a   Vashist, Urvish ^a   Sumashri, Kallukuri ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

Choroidal neovascularisation; Indian eyes; Myopia; Subretinal fibrosis; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HIGH MYOPIA; HUMAN; INDIAN; MALE; MYOPIA; PHOTODYNAMIC THERAPY; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

ADULT; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 5344234740     PISSN: 03014738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Green JS, Bear JC, Johnson GJ. The burden of genetically determined eye disease. Br J Ophthalmol 1986;70:696-99.
2. Montero JA, Ruiz-Moreno JM. Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation. Br J Ophthalmol 2003;87:173-76.
3. Yoshida T, Ohno-Matsui K, Yasuzumi K, Kojima A, Shimada N, Futagami S, Tokoro T et al. Myopic choroidal Neovascularisation. A 10 year follow-up. Ophthalmology 2003;110:1297-305.
4. Secretan M, Kuhn D, Soubrane G, Coscas G. Long term visual outcome of choroidal neovascularisation in pathologic myopia: Natural history and laser treatment. Eur J Ophthalmol 1997;7:307-16.
5. Ruiz-Moreno JM, Montero JA. Visual acuity results after argon green laser photocoagulation of juxtafoveal choroidal neovascularisation in highly myopic eyes: Long term results. Eur J Ophthalmol 2002;12:117-22.
6. Kobayashi H, Kobayashi K. Radiotherapy for subfoveal neovascularisation associated with pathological myopia: pilot study. Br J Ophthalmol 2000;84:761-66.
7. Adelberg DA, del Priore LV, Kaplan HJ. Surgery for subfoveal membranes in myopia, angioid streaks and other disorders. Retina 1995;15:198-205.
8. Ruiz-Moreno JM, de la Vega C. Surgical removal of subfoveal choroidal neovascularisation in highly myopic patients. Br J Ophthalmol 2001;85:1041-43.
9. Fujikado T, Ohji M, Saito Y, Hayashi Y, Tano Y. Visual function after foveal translocation with scleral shortening in patients with myopic neovascular maculopathy. Am J Ophthalmol 1998;125:647-56.
10. Fujikado T, Ohji M, Kusaka S, Hayashi A, Kamei M, Okada AA, et al. Visual function after foveal translocation with 360 - degree retinotomy and simultaneous torsional muscle surgery in patients with myopic neovascular maculopathy. Am J Ophthalmol 2001;131:101-10.
11. Fujikado T, Ohji M, Hayashi A, Kusaka S, Tano Y. Anatomic and functional recovery of the fovea after foveal translocation surgery without large retinotomy and simultaneous excision of a neovascular membrane. Am J Opthalmol 1998;126:839-42.
12. Verteporfin in Photodynamic therapy (VIP) Study Group. Photodynamic therapy of Subfoveal Choroidal Neovascularisation in pathologic myopia with verteporfin. 1 year results of a randomized clinical trial. VIP report No. 1. Ophthalmology 2001;108:841-52.
13. Verteporfin in Photodynamic therapy (VIP) Study Group. Photodynamic therapy of Subfoveal Choroidal Neovascularisation in pathologic myopia with verteporfin. 2 year results of a randomized clinical trial. VIP report No. 3. Ophthalmology 2003;110:667-73.
14. Treatment of Age Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularisaton in age related macular degeneration with verteporfin: One year results of 2 randomised clinical trials. TAP report 1. Arch Ophthalmol 1999;117:1329-45.
15. Ruiz-Moreno JM, Montero JA. Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes. Br J Ophthalmol 2003;87:856-59.
16. Miller JW, Walsh AW, Kramer M, Hasan T, Michaud N, Flotte TJ, et al. Photodynamic therapy of experimental choroidal neovascularisation using lipoprotein delivered benzoporphyrin. Arch Ophthalmol 1995;113:810-18.
17. Schmidt Erfurth U, Hasan T, Gragoudas E, Michaund N, Flotte TJ et al. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 1994;101:1953-61.
18. Wachtlin J, Behme T, Heimann H, Kellner U, Foerster MH. Concentric retinal pigment epithelial atrophy after single photodynamic therapy. Graefe's Arch CHn Exp Ophthalmol. 2003;241:518-21.